P1.126. Synchronous Head and Neck Squamous Cell Carcinoma and Esophageal Squamous Cell Carcinoma Treatment Experience From CMUH

Clicks: 25
ID: 325929
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #33 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Topic Esophageal Cancer: Oncology/Radiation Therapy Background Esophageal squamous cell carcinoma account for 53% of esophageal tumor has high mortality due to exposure of carcinogens in Asian country. Head and neck cancer had high synchronous association with esophageal cancer due to “field-cancerization” to the upper aerodigestive tract. 15–20% of patients with HNC (head and neck squamous cell carcinoma had a secondary EC (esophageal squamous cell carcinoma) in Taiwan. Treatment choice and outcomes of synchronous HNC and EC were limited. Methods We retrospectively enrolled 123 patients from 2015 to 2017 with synchronous head and neck cancer and esophageal cancer newly diagnosed and been treated in China medical university hospital in Taiwan. The individual treatment process including date of diagnosis, clinical presentation, lab data, pathology, surgery process, chemotherapy regiment, radiation dose, treatment outcome and adverse effects were reviewed. We excluded those patients with metastatic disease or those who had a history of malignancy prior to first being treated for the EC. The pathologies of all the cases of esophageal cancer and head/neck cancer were all squamous cell carcinoma. The tumor stages were determined according to the 8th American Joint Committee on Cancer (AJCC) staging system. Results Of all 123 patients with locally advanced synchronous HNC and EC, all the patients were male and the mean age was 54.29 years. For the EC, 48 patients (39.02%) were found to have a stage I tumor, 71 patients (57.73%) were found to have a stage II tumor, and 4 patients (3.25%) were found to have a stage III tumor, while for the HNC patients, 44 patients (35.77%) were found to have a stage I tumor, 33 patients (26.83%) were found to have stage II tumor, 22 patients (17.89%) were found to have a stage III tumor, and 24 patients (19.61%) were found to have a stage IVA or stage IVB tumor. 15 patients (12.2%) with early HNC and early EC; 24 patients (19.5%) with early HNC and late EC; 49 patients (39.8%) with late HNC and early EC; and 35 patients with late HNC and EC. Conclusion In our study, we found that in early HNC and EC patient 53.33% (n=8) received one-stage concurrent surgical resection and reconstruction of synchronous cancer. 2 patients in early HNC and late EC group; 23 patients in late HNC and early EC group; and 11 patients in late HNC and late EC group had operation followed by induction therapy. Although the procedures are highly invasive, and complicated, the outcomes can be promising. Our findings indicate that patients with late stage synchronous HNC and EC experienced poorer treatment outcomes than those with early stage synchronous HNC and EC, characterized by inferior prognoses.
Reference Key
openalex_W7203967780 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.274
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.